Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元

市场透视2024-12-23

北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-1.44倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2493765146?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-23 22:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493765146","market":"us","top_or_hot":-1,"title":"Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-1.44倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-23 22:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-1.44倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NRSN","symbol_name":"Neurosense Therapeutics Ltd","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","article_id":"2493765146","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493765146","pubTimestamp":1734964517,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.14%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NRSN":"Neurosense Therapeutics Ltd","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Neurosense Therapeutics Ltd. stock plunges 19.49%, market value falls $4.9355 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRSN":1,"LENZ":1},"content_text":"北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.15百万美元，每股收益-0.11美元，毛利0.00美元，市盈率-1.44倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为672.85%、451.00%、305.53%，振幅较大的相关个股有Traws Pharma, Inc.、Gt Biopharma, Inc.、Rapt Therapeutics, Inc.，振幅分别为39.04%、38.97%、36.35%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症（ALS），阿尔茨海默病和帕金森病等。该公司的候选产品PrimeC是一种新型的缓释口服制剂，由FDA批准的两种非专利药物环丙沙星和塞来昔布按特定比例组合而成的固定剂量组合。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493765146","isCrawlerRequest":true}